68 related articles for article (PubMed ID: 7959816)
1. Local identifiability of a receptor-binding radiopharmacokinetic system having measured parameters of known uncertainty.
Vera DR; Scheibe PO; Banin Y; Stadalnik RC
IEEE Trans Biomed Eng; 1994 Sep; 41(9):891-7. PubMed ID: 7959816
[TBL] [Abstract][Full Text] [Related]
2. Goodness-of-fit and local identifiability of a receptor-binding radiopharmacokinetic system.
Vera DR; Scheibe PO; Krohn KA; Trudeau WL; Stadalnik RC
IEEE Trans Biomed Eng; 1992 Apr; 39(4):356-67. PubMed ID: 1592401
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of a receptor-binding radiopharmacokinetic model.
Vera DR; Stadalnik RC; Metz CE; Pimstone NR
J Nucl Med; 1996 Jan; 37(1):160-4. PubMed ID: 8543988
[TBL] [Abstract][Full Text] [Related]
4. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin.
Vera DR; Stadalnik RC; Trudeau WL; Scheibe PO; Krohn KA
J Nucl Med; 1991 Jun; 32(6):1169-76. PubMed ID: 2045930
[TBL] [Abstract][Full Text] [Related]
5. Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity.
Kudo M; Vera DR; Trudeau WL; Stadalnik RC
Int J Rad Appl Instrum B; 1991; 18(7):663-6. PubMed ID: 1787074
[TBL] [Abstract][Full Text] [Related]
6. Automatic preparation of radiopharmacokinetic data for in vivo estimation of receptor biochemistry.
Xu JC; Vera DR; Stadalnik RC
J Nucl Med; 1996 Nov; 37(11):1896-902. PubMed ID: 8917199
[TBL] [Abstract][Full Text] [Related]
7. Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.
Vera DR; Woodle ES; Stadalnik RC
J Nucl Med; 1989 Sep; 30(9):1519-30. PubMed ID: 2549225
[TBL] [Abstract][Full Text] [Related]
8. Uncertainty analysis of (99m)Tc-HEPIDA liver clearance determination.
Surma MJ
Nucl Med Rev Cent East Eur; 2005; 8(2):116-24. PubMed ID: 16437397
[TBL] [Abstract][Full Text] [Related]
9. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
Kudo M; Vera DR; Trudeau WL; Stadalnik RC
J Nucl Med; 1991 Jun; 32(6):1177-82. PubMed ID: 2045931
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog.
Pimstone NR; Stadalnik RC; Vera DR; Hutak DP; Trudeau WL
Hepatology; 1994 Oct; 20(4 Pt 1):917-23. PubMed ID: 7927233
[TBL] [Abstract][Full Text] [Related]
11. Asialoglycoproteins as radiodiagnostic agents for detection of hepatic masses and evaluation of liver function.
Makdisi WF; Versland MR
Targeted Diagn Ther; 1991; 4():151-62. PubMed ID: 1665718
[TBL] [Abstract][Full Text] [Related]
12. In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model.
Stadalnik RC; Kudo M; Eckelman WC; Vera DR
Invest Radiol; 1993 Jan; 28(1):64-70. PubMed ID: 8425855
[No Abstract] [Full Text] [Related]
13. Functional liver imaging with 99Tcm-galactosyl-neoglycoalbumin (NGA) in alcoholic liver cirrhosis and liver fibrosis.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Nucl Med Commun; 1991 Jun; 12(6):507-17. PubMed ID: 1866104
[TBL] [Abstract][Full Text] [Related]
14. Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Wien Klin Wochenschr; 1991; 103(15):458-61. PubMed ID: 1926872
[TBL] [Abstract][Full Text] [Related]
15. [Clinical application of asialoglycoprotein receptor-mediated liver scintigraphy using 99mTc-DTPA-galactosyl-human serum albumin].
Ha-Kawa SK; Nakanishi Y; Kojima M; Tanaka Y; Kitagawa S; Kubota Y; Inoue K; Ikekubo K
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Dec; 51(12):1489-97. PubMed ID: 1792157
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic studies on 99mTc-NGA in human].
Guan C; Chen Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):268-70. PubMed ID: 8288194
[TBL] [Abstract][Full Text] [Related]
17. Assessment of accuracy and precision of (99m)Tc-HEPIDA clearances determined by means of a simplified method.
Surma MJ
Nucl Med Rev Cent East Eur; 2009; 12(1):14-22. PubMed ID: 19554517
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.
Stadalnik RC; Vera DR; Woodle ES; Trudeau WL; Porter BA; Ward RE; Krohn KA; O'Grady LF
J Nucl Med; 1985 Nov; 26(11):1233-42. PubMed ID: 2997417
[TBL] [Abstract][Full Text] [Related]
19. Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system.
Vera DR; Krohn KA; Scheibe PO; Stadalnik RC
IEEE Trans Biomed Eng; 1985 May; 32(5):312-22. PubMed ID: 3997184
[No Abstract] [Full Text] [Related]
20. Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepatocellular damage.
Kudo M; Todo A; Ikekubo K; Hino M
Am J Gastroenterol; 1992 Jul; 87(7):865-70. PubMed ID: 1615940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
